1-{[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-19-hydroxy-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolyllysylglycinamide,57511-54-3 Products Supply

Name: 1-{[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-19-hydroxy-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolyllysylglycinamide
CAS NO.: 57511-54-3
Synonyms:
1-{[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-19-hydroxy-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolyllysylglycinamide;AC1L4SKG;AC1Q5JBU;AR-1B9636;(1-(2-Hydroxy-3-mercaptopropanoic acid)-8-lys)vasopressin;(1-(2-Hydroxy-3-mercaptopropanoic acid)-8-lysine)vasopressin;Vasopressin, (1-(2-hydroxy-3-mercaptopropanoic acid)-8-lys)-;Vasopressin, (1-(2-hydroxy-3-mercaptopropanoic acid)-8-lysine)-;Vasopressin, 1-(2-hydroxy-3-mercaptopropanoic acid)-8-L-lysine-, (R)-;N-[6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-19-hydroxy-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide
Molecular Structure:
Molecular Formula: C₄₆H₆₄N₁₂O₁₃S₂

Send a message direct to supplier(s)*

Please post your buying leads,so that our qualified suppliers will soon contact you!

CAS NO.：
* Purchase Request：

* Your Email：
* Name：
* Gender：	Male Female
* Country/Area：
* Company Name：
* Tel：	- - Country - Code Area - Code Number

* Message：

Related products: 1-{[7-(2-amino-2-oxoethyl)-10-; 1-{[7-(2-amino-2-oxoethyl)-10-; 1-{[7-(2-amino-2-oxoethyl)-13-; 1-{[(4R,7S,10S,13R,16S,19R)-19; 1-{[7-(2-amino-2-oxoethyl)-10-; 1-{[7-(2-amino-2-oxoethyl)-10-; 1-{[(4R,7S,10S,16S,19R)-19-ami; 1-{[(4R,7S,10S,16S,19R)-19-ami; 1-{[(4R,7S,10S,16S,19R)-19-ami; 1-{[(4R,7S,10S,13S,16S)-7-(2-a; 1-{[11-(2-amino-2-oxoethyl)-8-; 1/C11H14N2O6/c1-17-7(14)4-12-2; 1-{[7-(2-amino-2-oxoethyl)-10-; 1-{[(4R,7S,10S,16S)-7-(2-amino; 1-{[7-(2-amino-2-oxoethyl)-10-; 1/C12H10N4O3/c1-3-19-12(18)10-; 1-{[(4R,7S,10S,16S,19R)-19-ami; 1-{[(2S,8S,11S,14S,19S)-19-ami; 1-{[(4R,7S,10S,16S,19R)-7-(2-a; 1-{[7-(2-amino-2-oxoethyl)-10-; 1-{[(4R,7S,10S,16S,19R)-19-ami; 1-{[(4R,7S,10S,16S,19R)-19-ami; N-{[(2S)-1-{[(4R,7S,10S,16S,19; 1-{[(4R,7S,10S,16S,19R)-7-(2-a; 1-{[7-(2-amino-2-oxoethyl)-10-; 1-{[(4R,7S,10S,13R,16S,19R)-19; 1/C14H9Br2O2P/c15-11-6-8-13(17; 1/C15H10O4/c16-11-7-3-1-5-9(11; 1/C22H28O6/c1-23-17-11-21(27-5; 1/C18H19NO4/c1-22-15-8-11-10(7;